Beijing Tiantan Hospital
Clinical trials sponsored by Beijing Tiantan Hospital, explained in plain language.
-
Can a daily pill and a simple physical therapy delay moyamoya strokes?
Disease control Not yet recruitingThis trial tests whether aspirin and a non-invasive physical therapy called ischemic conditioning can slow the progression of moyamoya disease, a rare brain vessel disorder that can cause strokes and cognitive decline. The study enrolls adults with moyamoya disease or syndrome wh…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can flickering light and sound slow Alzheimer's?
Disease control Not yet recruitingThis trial tests whether a device delivering synchronized 40-Hz light and sound stimulation can safely improve cognitive function in people with early Alzheimer's disease. Sixty participants with mild cognitive impairment or mild dementia due to Alzheimer's will receive either ac…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a nerve pain drug boost bladder pain relief?
Disease control Not yet recruitingThis trial is testing whether adding the nerve pain medication pregabalin to a structured educational and behavioral program can better ease the symptoms of bladder pain syndrome (also called interstitial cystitis) than the program alone. Adults with this condition will be random…
Phase: PHASE1 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New platform trial takes on NF2 tumors with multiple drug strategies
Disease control Not yet recruitingThis trial tests several drugs in people with NF2-related schwannomatosis, a condition that causes tumors on nerves and in the brain. The study uses a flexible 'platform' design to evaluate treatments for four tumor types: vestibular schwannomas, non-vestibular schwannomas, menin…
Phase: PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a cancer drug shrink brain tumors and save hearing in a rare nerve disorder?
Disease control Not yet recruitingThis trial tests the drug selumetinib in people with NF2-related schwannomatosis, a genetic condition that causes non-cancerous tumors on nerves, often leading to hearing loss. The study includes both adults and children whose tumors cannot be surgically removed or are growing. R…
Phase: PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Drug combo aims to shrink NF2 tumors and save hearing
Disease control Not yet recruitingThis trial tests whether combining two drugs—luvometinib (a targeted therapy) and serplulimab (an immunotherapy)—can shrink tumors and improve hearing in people with NF2-related schwannomatosis. Participants have progressive vestibular schwannomas or meningiomas that are not suit…
Phase: PHASE1, PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Sleep drug may shield elderly brains from Post-Surgery confusion
Disease control Not yet recruitingThis study tests whether lemborexant, a sleep medication, can reduce postoperative delirium—a state of confusion and disorientation—in patients aged 60 and older after elective surgery under general anesthesia. Participants receive either lemborexant or a placebo before and after…
Phase: PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Cancer drug repurposed to calm brain inflammation in autoimmune disease
Disease control Not yet recruitingThis study tests whether a low dose of blinatumomab, a drug originally used for leukemia, can help people with severe autoimmune encephalitis or cerebellitis that hasn't responded to standard treatments. The drug targets and depletes certain immune cells (B cells) that are mistak…
Phase: PHASE4 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New hybrid stroke unit aims to cut lifesaving treatment time
Disease control Not yet recruitingThis phase 3 trial tests whether a new emergency stroke unit, equipped with a hybrid CT and X-ray machine (NeuAngio-CT), can speed up clot removal in people having a severe stroke. About 232 adults aged 18-60 with acute ischemic stroke will be randomly assigned to either the new …
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Nerve block may boost brain recovery after hemorrhagic stroke
Disease control Not yet recruitingThis study tests whether a stellate ganglion block (a nerve block injection) can improve neurological outcomes in people who have had a bleeding stroke from a ruptured aneurysm. The procedure is done before surgery to reduce brain artery spasms and improve blood flow. Researchers…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Personalized brain zaps aim to boost stroke recovery in major trial
Disease control Not yet recruitingThis study tests whether a non-invasive brain stimulation technique called cTBS, guided by each patient's brain scan, can improve arm and leg movement after a stroke. About 584 adults who had a stroke within the past two weeks will receive either real or sham stimulation alongsid…
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can zapping the brain help stroke patients move again?
Disease control Not yet recruitingThis study tests a personalized brain stimulation technique called cTBS to help people recover movement after a stroke. Researchers use each patient's brain scan to target the stimulation precisely. Sixty participants will receive either real or sham stimulation alongside standar…
Phase: PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Robot arm takes on stroke complication in first human test
Disease control Not yet recruitingThis early-stage trial tests whether a robot can safely help remove blood clots in the brain that form after standard stroke treatments. About 20 adults who develop a specific type of bleeding will undergo a robot-assisted procedure to suction out the clot, followed by a clot-bus…
Phase: PHASE1 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Gut bacteria pill could slow Alzheimer's decline
Disease control Not yet recruitingThis study tests an oral medication called Gut-X-001 in 120 people with Alzheimer's disease. The goal is to see if it can improve thinking, daily living skills, and brain health. Participants will receive the drug or a placebo for 6 months, with an option to continue for another …
Phase: PHASE1, PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Blood patch showdown: could Platelet-Rich plasma beat whole blood for rare headache condition?
Disease control Not yet recruitingThis study tests whether a patch made from a patient's own platelet-rich plasma works better than a standard whole blood patch for treating spontaneous intracranial hypotension, a condition causing severe headaches from spinal fluid leaks. About 218 adults who haven't improved wi…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Personalized blood pressure after stroke could boost recovery
Disease control Not yet recruitingThis study tests whether managing blood pressure based on the brain's collateral circulation (backup blood flow) after stroke treatment leads to better recovery. About 544 adults who had a stroke due to a large artery blockage and received endovascular therapy will be enrolled. P…
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New shot aims to slash stroke risk by crushing cholesterol
Disease control Not yet recruitingThis Phase 3 trial tests a new injectable drug, ongericimab, in about 4,800 people who recently had a stroke due to narrowed arteries. The goal is to see if lowering LDL cholesterol more than current standard care can prevent future strokes, heart attacks, or death from heart dis…
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Brain tumor surgery: new drug may cut stroke risk
Disease control Not yet recruitingThis study tests whether the anti-inflammatory drug ulinastatin can prevent strokes in people having brain tumor removal. About 1,370 patients will receive either ulinastatin or a placebo before and after surgery. The goal is to see if the drug lowers the chance of having a strok…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New combo treatment aims to reduce disability after brain hemorrhage
Disease control Not yet recruitingThis study tests a new approach for people with a serious type of brain bleed (lobar intracerebral hemorrhage). It combines a highly precise, computer-guided surgery to drain the blood with a clot-busting drug called tenecteplase. The goal is to see if this treatment helps more p…
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Stroke patients may get faster lifesaving care by skipping standard scans
Disease control Not yet recruitingThis study tests whether sending people with suspected severe stroke directly to the angiography suite (instead of first getting a CT or MRI) can speed up treatment and improve recovery. About 568 adults with stroke symptoms within 6 hours will be randomly assigned to the direct …
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could anakinra save brain tissue after a stroke? new trial aims to find out
Disease control Not yet recruitingThis study tests whether the drug anakinra can limit brain damage in people who have had a severe stroke and have already undergone a procedure to remove a blood clot. About 159 adults aged 18-80 will receive either standard care or anakinra at different doses. The main goal is t…
Phase: PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New shot could cut stroke risk for High-Risk patients
Disease control Not yet recruitingThis study tests whether adding a drug called Tafolecimab to standard cholesterol-lowering therapy can reduce the risk of another stroke in people who have had a recent stroke or mini-stroke and have high levels of Lp(a), a type of fat in the blood. About 242 participants will re…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New stroke drug combo aims to boost recovery in major trial
Disease control Not yet recruitingThis study tests whether adding the blood thinner tirofiban after standard stroke treatment helps people recover better from a severe type of stroke caused by a blocked large artery in the brain. About 564 adults in China will receive either tirofiban or usual care after their in…
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for severe stroke: clot removal procedure tested
Disease control Not yet recruitingThis study tests whether a procedure to remove blood clots from the brain can help people who have had a severe stroke. The trial will include 308 adults aged 18 to 80 with a large area of brain damage. Doctors will use special tools to clear the blocked artery and then check how…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could a sleep drug fix chronic insomnia? new trial aims to find out
Disease control Not yet recruitingThis study tests whether a drug called dexmedetomidine, given through an IV to induce sleep, can help people with severe insomnia that hasn't improved with other treatments. 180 adults aged 18-65 will receive either the drug plus standard oral medication or standard medication al…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New combo therapy aims to cut disability after 'silent' strokes
Disease control Not yet recruitingThis study tests whether two medicines, isosorbide mononitrate and butylphthalide, can reduce disability in people who recently had a lacunar stroke (a small stroke deep in the brain). About 3,156 adults aged 30 and older will receive one or both drugs or placebos for up to a yea…
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a common drug prevent brain damage after a stroke?
Disease control Not yet recruitingThis study tests whether the drug cilostazol can prevent delayed brain injury in people who have had a bleeding stroke from a burst aneurysm. About 316 adults will receive either cilostazol or a placebo for 14 days. The goal is to see if the drug reduces the risk of delayed brain…
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can herbal pills cut stroke risk after brain bleed? major trial launches
Disease control Not yet recruitingThis study tests whether a Chinese herbal pill (Naoxuekang Dropping Pills) can lower the chance of having another stroke, heart attack, or blood clot in people who recently had a brain bleed from high blood pressure. About 1,950 adults will take either the pill or a placebo for 9…
Phase: PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can raising blood pressure after brain bleed surgery boost recovery?
Disease control Not yet recruitingThis study tests whether raising or lowering blood pressure after aneurysm repair improves outcomes in people with a brain bleed. 750 adults who had surgery within 72 hours will be randomly assigned to different blood pressure targets. Their recovery will be tracked for 6 months …
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:52 UTC
-
Antidepressant venlafaxine put to the test against chronic back pain
Symptom relief Not yet recruitingThis trial tests whether the antidepressant venlafaxine can reduce pain and improve function in adults with chronic non-specific low back pain. Participants receive either venlafaxine (up to 225 mg daily) plus routine care, or routine care alone, for three months. The study measu…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Could an antidepressant ease chronic bladder pain? new trial investigates
Symptom relief Not yet recruitingThis trial compares two approaches for adults with interstitial cystitis, a condition causing long-term bladder pain and frequent urination. All participants receive education and behavioral training, while half also take the antidepressant venlafaxine for 12 weeks. Researchers w…
Phase: PHASE1 • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Could a common cold sore drug ease facial pain? new trial investigates
Symptom relief Not yet recruitingThis trial compares three treatments for idiopathic trigeminal neuralgia, a condition causing severe facial pain. One group gets standard carbamazepine alone, another adds the antiviral acyclovir, and the third adds the anti-inflammatory celecoxib. The goal is to see which combin…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New painkiller aims to prevent gut woes after brain surgery
Symptom relief Not yet recruitingThis study tests whether a drug called oliceridine can reduce stomach and bowel problems after brain surgery. About 176 adults having brain tumor removal will receive either oliceridine or a standard opioid during surgery. The goal is to see if oliceridine lowers the risk of naus…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Patch before surgery may cut painkiller use after lung operations
Symptom relief Not yet recruitingThis study tests whether placing a loxoprofen sodium patch on the skin before video-assisted lung surgery can reduce pain and the need for strong painkillers afterward. About 156 adults aged 18 to 64 having lung surgery will be randomly assigned to get the patch or a placebo. The…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
New ICU strategy skips sedatives, uses only painkillers after brain surgery
Symptom relief Not yet recruitingThis study explores whether giving only pain medicine (remifentanil) without sedatives is safe and feasible for adults in the ICU after brain surgery. The goal is to avoid side effects of sedatives, like confusion or hiding signs of brain problems. Sixty-five participants will be…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Mind-Controlled robot arm therapy could restore movement after stroke
Symptom relief Not yet recruitingThis study will test a new type of rehabilitation robot that uses brain signals and mirror therapy to help stroke patients with arm weakness. The robot is non-invasive and designed to encourage the brain to re-learn movement. Researchers will enroll 40 adults aged 30 to 80 who ha…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New painkiller aims to stop Post-Surgery pain before it starts
Symptom relief Not yet recruitingThis study tests whether a new form of the anti-inflammatory drug dexamethasone (called dexamethasone palmitate) can prevent moderate-to-severe pain after surgery better than the standard version. About 446 adults having various surgeries will receive the drug before their operat…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
One-Stop stroke suite could save minutes and brains
Symptom relief Not yet recruitingThis study compares a new 'one-stop' emergency stroke unit that combines CT scanning and treatment in one room to the usual process where scans and treatment happen in separate places. The goal is to see if this faster approach helps more people recover with little or no disabili…
Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New combo aims to cut opioids and confusion after brain surgery
Symptom relief Not yet recruitingThis study tests if using scalp nerve blocks and a drug called dexmedetomidine can reduce the need for strong opioid painkillers and prevent confusion after brain tumor surgery. About 2000 adults having brain surgery will be randomly assigned to receive one or both treatments, or…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New pain cocktail aims to cut opioid use after brain surgery
Symptom relief Not yet recruitingThis study tests a combination of two pain-relief methods—a sedative drug called dexmedetomidine and a local anesthetic injected into the scalp—for people undergoing brain tumor surgery. The goal is to see if this approach reduces the need for strong opioid painkillers after surg…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New combo aims to ease fibromyalgia pain better than standard drug
Symptom relief Not yet recruitingThis study tests whether adding tizanidine (a muscle relaxant) to pregabalin (a standard pain drug) works better than pregabalin alone for fibromyalgia pain. About 164 adults with daily pain will be followed for 12 weeks. The goal is to see if the combination reduces pain and imp…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Could a steroid injection stop shingles pain for good?
Symptom relief Not yet recruitingThis study tests whether dexamethasone palmitate, a steroid, can better relieve shingles pain and prevent long-term nerve pain compared to standard care. About 954 adults with shingles rash and severe pain will receive the drug by injection or infusion. Researchers will track pai…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Nerve block before surgery may boost sleep and recovery in brain injury patients
Symptom relief Not yet recruitingThis study tests whether a stellate ganglion block—a nerve block using the drug ropivacaine—given before surgery can improve sleep and recovery in 25 patients with prolonged disorders of consciousness after brain injury. Researchers will measure sleep time, brain oxygen levels, a…
Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Brain scans reveal secret language superpower in AVM patients
Knowledge-focused Not yet recruitingThis study will scan the brains of 120 people with brain arteriovenous malformations (AVMs) to understand why their language stays normal even when the left side of the brain is damaged. Using advanced MRI, researchers will look at how the right hemisphere reorganizes to handle s…
Sponsor: Beijing Tiantan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New brain monitoring tech could predict strokes during heart surgery
Knowledge-focused Not yet recruitingThis study looks at whether using multiple brain monitoring tools together can help predict strokes in people having heart surgery. About 369 high-risk patients will be watched during surgery to see if the monitoring can give early warning. The goal is to find better ways to prot…
Sponsor: Beijing Tiantan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC